Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mercado, José Darío"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Niño, María Claudia, Mejía, Juan Armando, Cohen, Darwin, Mojica, Viviana, Rojas, María Fernanda, Mercado, José Darío, González, Mariana, Madrid, Guillermo
Publikováno v:
Anesthesia & Analgesia; Aug2021, Vol. 133 Issue 2, pe20-e22, 3p
Publikováno v:
Estadísticas del tumor cerebral | Asociación Estadounidense del Tumor Cerebral [Internet]. [cited 2018 Feb 24]. Available from: http://www.abta.org/about-us/news/brain-tumor-statistics/
ABTA. Brain Tumor Statistics [Internet]. Brain Tumor Statistics. Available from: http://www.abta.org/about-us/news/brain-tumor-statistics/
Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol [Internet]. 2017;19(suppl_5):v1–88. Available from: http://academic.oup.com/neuro-oncology/article/19/suppl_5/v1/4596648
Pardo C, Cendales R. Incidencia, mortalidad y prevalencia de Cáncer en Colombia 2007-2011 [Internet]. Vol. 1, Instituto Nacional De Cancerologia. 2015. 148 p. Available from: http://www.cancer.gov.co/files/libros/archivos/incidencia1.pdf
DIEA. Anuario estadístico. 2016;198. Available from: www.mgap.gub.uy
De La Garza-Ramos R, Kerezoudis P, Tamargo RJ, Brem H, Huang J, Bydon M. Surgical complications following malignant brain tumor surgery: An analysis of 2002-2011 data. Clin Neurol Neurosurg [Internet]. 2016;140:6–10. Available from: http://dx.doi.org/10.1016/j.clineuro.2015.11.005
Helal AE, Abouzahra H, Fayed AA, Rayan T, Abbassy M. Socioeconomic restraints and brain tumor surgery in low-income countries. Neurosurg Focus. 2018;45(4):1–5.
Mariappan R, Venkatraghavan L, Vertanian A, Agnihotri S, Cynthia S, Reyhani S, et al. Serum lactate as a potential biomarker of malignancy in primary adult brain tumours. J Clin Neurosci [Internet]. 2015;22(1):144–8. Available from: http://dx.doi.org/10.1016/j.jocn.2014.06.005
Jianrong Lua, Ming Tanb and QC. The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism. 2016;356(2):156–64.
Choi SYC, Collins CC, Gout PW, Wang Y. Cancer-generated lactic acid: A regulatory, immunosuppressive metabolite? J Pathol. 2013;230(4):350–5.
Barros LF, Deitmer JW. Glucose and lactate supply to the synapse. Brain Res Rev [Internet]. 2010;63(1–2):149–59. Available from: http://dx.doi.org/10.1016/j.brainresrev.2009.10.002
Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: A retrospective outcome evaluation of critically ill patients. Crit Care. 2006;10(1):1–9.
Lee Y, Kim W, Yoo J, Jung H, Min T. Correlation between regional tissue perfusion saturation and lactate level during cardiopulmonary bypass. Korean Journal of Anesthesiology. 2018;71(5):361-367.
Kraut JA, Madias NE. Lactic Acidosis. N Engl J Med [Internet]. 2014;371(24):2309–19. Available from: http://www.nejm.org/doi/10.1056/NEJMra1309483
Mesquida J, Borrat X, Lorente JA, Masip J, Baigorri F. Objetivos de la reanimación hemodinámica. Med Intensiva. 2011;35(8):499–508.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Vol. 45, Critical Care Medicine. 2017. 486-552 p.
Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through β2 stimulation is a common mechanism involved in lactate formation during shock states. Shock. 2008;30(4):417–21.
Okorie ON, Dellinger P. Lactate: Biomarker and Potential Therapeutic Target. Crit Care Clin. 2011;27(2):299–326.
Bertram JS. The molecular biology of cancer. Mol Aspects Med. 2000;21:167–223.
Poff A, Koutnik AP, Egan KM, Sahebjam S, D’Agostino D, Kumar NB. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Semin Cancer Biol [Internet]. 2019;56:135–48. Available from: http://dx.doi.org/10.1016/j.semcancer.2017.12.011
Vander Heiden MG, Cantley LC, ompson CB. Understanding the Warburg effect: e metabolic requirements of cell proliferation. Science 2009;324:1029-33
Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. International Journal of Radiation Biology. 2019;95(7):912-919.
Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, et al. Metabolic Targeting of Lactate Efflux by Malignant Glioma Inhibits Invasiveness and Induces Necrosis: An In Vivo Study. Neoplasia [Internet]. 2011;13(7):620–32. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1476558611800266
Walenta S, Salameh a, Lyng H, Evensen JF, Mitze M, Rofstad EK, et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol. 1997;150(2):409–15.
Bharadwaj S, Venkatraghavan L, Mariappan R, Ebinu J, Meng Y, Khan O, et al. Serum lactate as a potential biomarker of non-glial brain tumors. J Clin Neurosci [Internet]. 2015;22(10):1625–7. Available from: http://dx.doi.org/10.1016/j.jocn.2015.05.009
Cata JP, Bhavsar S, Hagan KB, Arunkumar R, Grasu R, Dang A, et al. Intraoperative serum lactate is not a predictor of survival after glioblastoma surgery. J Clin Neurosci [Internet]. 2017;43(2017):224–8. Available from: http://dx.doi.org/10.1016/j.jocn.2017.05.004
de Smalen PP, van Ark TJ, Stolker RJ, Vincent AJPE, Klimek M. Hyperlactatemia After Intracranial Tumor Surgery Does Not Affect 6-Month Survival. J Neurosurg Anesthesiol [Internet]. 2019;00(00):1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30913172%0Ahttp://Insights.ovid.com/crossref ?an=00008506-900000000-99164
Dong Z, Zhong X, Lei Q, Chen F, Cui H. Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells. Cell Signal [Internet]. 2019;60(2):100–13. Available from: https://doi.org/10.1016/j.cellsig.2019.04.009
Kohli-Seth R, Mukkera SR, Leibowitz AB, Nemani N, Oropello JM, Manasia A, et al. Frequency and Outcomes of Hyperlactatemia After Neurosurgery: A Retrospective Analysis. ICU Dir. 2011;2(6):211–4.
Okorie ON, Dellinger P. Lactate: Biomarker and potential therapeutic target. Crit Care Clin 2011;27:299-326.
Phypers B, Pierce JMT. Lactate physiology in health and disease. Contin Educ Anaesthesia, Crit Care Pain [Internet]. 2006;6(3):128–32. Available from: http://dx.doi.org/10.1093/bjaceaccp/mkl018
RomanoID D, Deiner S, Cherukuri A, Boateng B, Shrivastava R, Mocco J, et al. Clinical impact of intraoperative hyperlactatemia during craniotomy. PLoS One [Internet]. 2019;14(10):1–12. Available from: https://doi.org/10.1371/journal.pone.0224016
Ioannoni E, Grande G, Olivi A, Antonelli M, Caricato A, Montano N. Factors affecting serum lactate in patients with intracranial tumors-A report of our series and review of the literature. Surg Neurol Int • [Internet]. 2020 [cited 2020 Nov 5];11(39):1–5. Available from: www.surgicalneurologyint.com
Shih CC, Lee TS, Tsuang FY, Lin PL, Cheng YJ, Cheng HL, Wu CY. Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection. Oncotarget. 2017 Jun 29;8(38):63715-63723. doi: 10.18632/oncotarget.18891. PMID: 28969023; PMCID: PMC5609955.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
ABTA. Brain Tumor Statistics [Internet]. Brain Tumor Statistics. Available from: http://www.abta.org/about-us/news/brain-tumor-statistics/
Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol [Internet]. 2017;19(suppl_5):v1–88. Available from: http://academic.oup.com/neuro-oncology/article/19/suppl_5/v1/4596648
Pardo C, Cendales R. Incidencia, mortalidad y prevalencia de Cáncer en Colombia 2007-2011 [Internet]. Vol. 1, Instituto Nacional De Cancerologia. 2015. 148 p. Available from: http://www.cancer.gov.co/files/libros/archivos/incidencia1.pdf
DIEA. Anuario estadístico. 2016;198. Available from: www.mgap.gub.uy
De La Garza-Ramos R, Kerezoudis P, Tamargo RJ, Brem H, Huang J, Bydon M. Surgical complications following malignant brain tumor surgery: An analysis of 2002-2011 data. Clin Neurol Neurosurg [Internet]. 2016;140:6–10. Available from: http://dx.doi.org/10.1016/j.clineuro.2015.11.005
Helal AE, Abouzahra H, Fayed AA, Rayan T, Abbassy M. Socioeconomic restraints and brain tumor surgery in low-income countries. Neurosurg Focus. 2018;45(4):1–5.
Mariappan R, Venkatraghavan L, Vertanian A, Agnihotri S, Cynthia S, Reyhani S, et al. Serum lactate as a potential biomarker of malignancy in primary adult brain tumours. J Clin Neurosci [Internet]. 2015;22(1):144–8. Available from: http://dx.doi.org/10.1016/j.jocn.2014.06.005
Jianrong Lua, Ming Tanb and QC. The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism. 2016;356(2):156–64.
Choi SYC, Collins CC, Gout PW, Wang Y. Cancer-generated lactic acid: A regulatory, immunosuppressive metabolite? J Pathol. 2013;230(4):350–5.
Barros LF, Deitmer JW. Glucose and lactate supply to the synapse. Brain Res Rev [Internet]. 2010;63(1–2):149–59. Available from: http://dx.doi.org/10.1016/j.brainresrev.2009.10.002
Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: A retrospective outcome evaluation of critically ill patients. Crit Care. 2006;10(1):1–9.
Lee Y, Kim W, Yoo J, Jung H, Min T. Correlation between regional tissue perfusion saturation and lactate level during cardiopulmonary bypass. Korean Journal of Anesthesiology. 2018;71(5):361-367.
Kraut JA, Madias NE. Lactic Acidosis. N Engl J Med [Internet]. 2014;371(24):2309–19. Available from: http://www.nejm.org/doi/10.1056/NEJMra1309483
Mesquida J, Borrat X, Lorente JA, Masip J, Baigorri F. Objetivos de la reanimación hemodinámica. Med Intensiva. 2011;35(8):499–508.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Vol. 45, Critical Care Medicine. 2017. 486-552 p.
Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through β2 stimulation is a common mechanism involved in lactate formation during shock states. Shock. 2008;30(4):417–21.
Okorie ON, Dellinger P. Lactate: Biomarker and Potential Therapeutic Target. Crit Care Clin. 2011;27(2):299–326.
Bertram JS. The molecular biology of cancer. Mol Aspects Med. 2000;21:167–223.
Poff A, Koutnik AP, Egan KM, Sahebjam S, D’Agostino D, Kumar NB. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Semin Cancer Biol [Internet]. 2019;56:135–48. Available from: http://dx.doi.org/10.1016/j.semcancer.2017.12.011
Vander Heiden MG, Cantley LC, ompson CB. Understanding the Warburg effect: e metabolic requirements of cell proliferation. Science 2009;324:1029-33
Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. International Journal of Radiation Biology. 2019;95(7):912-919.
Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, et al. Metabolic Targeting of Lactate Efflux by Malignant Glioma Inhibits Invasiveness and Induces Necrosis: An In Vivo Study. Neoplasia [Internet]. 2011;13(7):620–32. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1476558611800266
Walenta S, Salameh a, Lyng H, Evensen JF, Mitze M, Rofstad EK, et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol. 1997;150(2):409–15.
Bharadwaj S, Venkatraghavan L, Mariappan R, Ebinu J, Meng Y, Khan O, et al. Serum lactate as a potential biomarker of non-glial brain tumors. J Clin Neurosci [Internet]. 2015;22(10):1625–7. Available from: http://dx.doi.org/10.1016/j.jocn.2015.05.009
Cata JP, Bhavsar S, Hagan KB, Arunkumar R, Grasu R, Dang A, et al. Intraoperative serum lactate is not a predictor of survival after glioblastoma surgery. J Clin Neurosci [Internet]. 2017;43(2017):224–8. Available from: http://dx.doi.org/10.1016/j.jocn.2017.05.004
de Smalen PP, van Ark TJ, Stolker RJ, Vincent AJPE, Klimek M. Hyperlactatemia After Intracranial Tumor Surgery Does Not Affect 6-Month Survival. J Neurosurg Anesthesiol [Internet]. 2019;00(00):1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30913172%0Ahttp://Insights.ovid.com/crossref ?an=00008506-900000000-99164
Dong Z, Zhong X, Lei Q, Chen F, Cui H. Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells. Cell Signal [Internet]. 2019;60(2):100–13. Available from: https://doi.org/10.1016/j.cellsig.2019.04.009
Kohli-Seth R, Mukkera SR, Leibowitz AB, Nemani N, Oropello JM, Manasia A, et al. Frequency and Outcomes of Hyperlactatemia After Neurosurgery: A Retrospective Analysis. ICU Dir. 2011;2(6):211–4.
Okorie ON, Dellinger P. Lactate: Biomarker and potential therapeutic target. Crit Care Clin 2011;27:299-326.
Phypers B, Pierce JMT. Lactate physiology in health and disease. Contin Educ Anaesthesia, Crit Care Pain [Internet]. 2006;6(3):128–32. Available from: http://dx.doi.org/10.1093/bjaceaccp/mkl018
RomanoID D, Deiner S, Cherukuri A, Boateng B, Shrivastava R, Mocco J, et al. Clinical impact of intraoperative hyperlactatemia during craniotomy. PLoS One [Internet]. 2019;14(10):1–12. Available from: https://doi.org/10.1371/journal.pone.0224016
Ioannoni E, Grande G, Olivi A, Antonelli M, Caricato A, Montano N. Factors affecting serum lactate in patients with intracranial tumors-A report of our series and review of the literature. Surg Neurol Int • [Internet]. 2020 [cited 2020 Nov 5];11(39):1–5. Available from: www.surgicalneurologyint.com
Shih CC, Lee TS, Tsuang FY, Lin PL, Cheng YJ, Cheng HL, Wu CY. Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection. Oncotarget. 2017 Jun 29;8(38):63715-63723. doi: 10.18632/oncotarget.18891. PMID: 28969023; PMCID: PMC5609955.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Objetivo: Identificar el lactato como predictor de desenlaces clínicos en el cuidado post operatorio de pacientes con resección de tumores cerebrales. Diseño. Estudio observacional de cohorte clínica prospectivo. Se incluyeron 224 pacientes en po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c360661316f25c79573e4ff5d56a9103
https://repository.urosario.edu.co/handle/10336/31903
https://repository.urosario.edu.co/handle/10336/31903
